Your browser doesn't support javascript.
loading
Efficacy and safety of tacrolimus-based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study.
Zhang, Xiao-Juan; Ji, Cheng-Fa; Yuan, Jiang-Zi; Wang, Lei; Zhang, Jing; Fang, Wei; Bai, Dong-Fang; Hu, Zhao.
Afiliación
  • Zhang XJ; Department of Nephrology, Qi Lu Hospital of Shandong University, Jinan, Shandong, China.
  • Ji CF; Department of Nephrology, Taian City Central Hospital, Taian, Shandong, China.
  • Yuan JZ; Shandong New Time Pharmaceutical Co., LTD., Lunan Pharmaceutical Group Co., Ltd., Linyi, Shandong, China.
  • Wang L; Department of Nephrology, RenJi Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang J; Department of Nephrology, Taian City Central Hospital, Taian, Shandong, China.
  • Fang W; Shandong New Time Pharmaceutical Co., LTD., Lunan Pharmaceutical Group Co., Ltd., Linyi, Shandong, China.
  • Bai DF; Department of Nephrology, RenJi Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Hu Z; Department of Nephrology, Taian City Central Hospital, Taian, Shandong, China.
Kaohsiung J Med Sci ; 35(10): 633-639, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31225949

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glomerulonefritis Membranosa / Tacrolimus / Inmunosupresores Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Kaohsiung J Med Sci Asunto de la revista: MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glomerulonefritis Membranosa / Tacrolimus / Inmunosupresores Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Kaohsiung J Med Sci Asunto de la revista: MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: China
...